Connecting Metabolism and Mind: Adipokines' Influence on Alzheimer's Progression
Exploring the intersections of metabolism and brain health, recent research illuminates how substances produced by fat cells, known as adipokines, along with insulin levels, correlate with brain degeneration and cognitive decline in Alzheimer’s disease. The study examined substances like leptin and adiponectin, revealing their association with changes in brain volume and cognitive abilities. Higher levels of certain adipokines were linked to increased brain atrophy and cognitive impairments, suggesting a profound metabolic influence on brain health.
Intriguingly, not all adipokines had detrimental effects; for instance, higher adiponectin levels were associated with better brain structure outcomes, highlighting a complex relationship between these metabolic regulators and brain health. This insight opens up potential pathways for targeted interventions that could mitigate the impacts of Alzheimer's by modulating metabolic factors.
These findings underscore the potential of metabolic health as a lever to influence brain health and Alzheimer's progression. The study advocates for a holistic approach to Alzheimer's treatment and prevention, integrating metabolic management to potentially slow or alter the course of cognitive decline.
Article Information
Published in Progress in Neuropsychopharmacology & Biological Psychiatry, Isabel Garcia-Garcia et al.
Abstract
The discovery that metabolic alterations often coexist with neurodegenerative conditions has sparked interest in the examination of metabolic regulatory factors as potential modulators of brain health. Here, we examined the role of adipokines (leptin, adiponectin, resistin, and IL6) and insulin on different markers of brain atrophy in participants on the spectrum of Alzheimer's Disease. We included 566 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset with 1063 follow-up time points (average follow-up: one year); and examined the association between metabolic regulatory factors and volumetric MRI values, white matter hyperintensities, and measures of cognitive impairment. Higher leptin, resistin, IL6, and insulin were associated with markers of cerebral atrophy, such as lower total brain volume, or higher ventricular volume. Higher leptin and resistin were also associated with greater impairment in daily life activities. Higher adiponectin was associated with lower ventricle volume. There was no association between adipokines or insulin with white matter hyperintensities. Our findings indicate a co-occurrence between alterations in metabolic regulatory factors and in brain volume along the preclinical to clinical spectrum of Alzheimer's Disease. These results suggest that strategies aimed at promoting metabolic health may positively impact brain health.
Bring preventive care to your clinic
© Longevity Artificial Intelligence. All rights reserved.